ClinicalTrials.gg
Drug

Heparin clinical trials

studies test it
150
open now
17
in phase 3
37
first study started
1994
Related medicines add 2 studies

Counted the way a researcher would: Heparin with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Heparin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Heparin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
9 Feb 1939 · HEPARIN SODIUM · NDA 000552 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Heparin
77
Unfractionated heparin
41
Heparin Sodium
15
Unfractioned heparin
3
Subcutaneous Heparin
3

Studies by the year they started

148 studies that test it; most in 2020 (18)

Studies that test Heparin, by start year
YearStudies
19941
19981
20001
20011
20034
20042
20055
20064
20075
20084
20094
20104
20117
20125
201312
20143
20155
20169
20175
20189
20197
202018
20219
20227
202310
20242
20251
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
16
Phase 2
32
Phase 3
37
Phase 4
42
No phase
35

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 133

University of Manitoba (4) · Australian National University (3) · Stanford University (3) · Azidus Brasil (3) · NYU Langone Health (2) · Ain Shams University (2) · Mayo Clinic (2) · Frederick Health (2)

Often tested with

Tested in the same studies.

Enoxaparin (11) · Bivalirudin (10) · Heparin, Low-Molecular-Weight (4) · Soybean oil, phospholipid emulsion (4) · Aspirin (4) · Tigecycline (2) · Enoxaparin sodium (2) · Fibroblast Growth Factor 7 (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5, 1 in phase 3

Studies that test Heparin, phase 3 first.

Studies

Open first, then newest update. How each study uses Heparin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 150

See all 150 studies that test Heparin →

Given beside what is tested · 26 — Heparin is usual care or a partner of the new treatment

Showing 20 of 26.

As the comparator · 102 — what is tested is compared with Heparin

Showing 20 of 102.

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call Heparin · ClinicalTrials.gg INT007603

  • MeSH (NLM) D006493HeparinConfirmed ClinicalTrials.gov, Wikidata
  • UNII (FDA) T2410KM04AHEPARINConfirmed FDA, Wikidata
  • RxNorm 5224Confirmed FDA, Wikidata
  • Wikidata Q190016heparinConfirmed FDA, Wikidata
  • NCI Thesaurus C539HeparinOne source FDA
  • DrugBank DB01109One source Wikidata

Also registered as heparin sodium (UNII ZZ45AB24CA · RxNorm 9877).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.